Andrew Ho (@Tru_Ho) profile picture

Andrew Ho

@Tru_Ho

Sleep Medicine Fellow/Former PCCM Fellow @TUH

 Philadelphia
Joined April 2009
  • Tweets14
  • Following284
  • Followers33
2Media
Photo by Andrew Ho (@Tru_Ho)Photo by Andrew Ho (@Tru_Ho)
#SLEEP2026: GLP-related home sleep testing made up 44% of primary care referrals, but many studies were negative or suboptimal, according to a late-breaking abstract. Details here: hubs.li/Q04m39Nq0
Image from Patient Care (@PatCareOnline)
1
21
Andrew Ho retweeted
HCPLive (@HCPLiveNews) profile picture
HCPLive
@HCPLiveNewsMay 19
Heart rate and the 6-minute walk test may predict which patients with #COPD are headed for hospitalization. Watch the interview with Andrew Ho, MD, @TempleUniv here: hcplive.com/view/heart-rate-… #COPD #PulmonaryMedicine #ATS2026
2
3
162
First time attending ERS #ERS2025! Our work on biologics in COPD shows reduced hospitalizations needing NIV & examined structural lung changes on quantitative CT. Discussion with @Medscape & @HealioPulm 👇 #COPD #Biologics @TemplePCCM @TempleLung
Image from Andrew Ho (@Tru_Ho)
2
2
88
Biologics May Promote Structural Lung Changes in Chronic Obstructive Pulmonary Disease medscape.com/viewarticle/bio… medscape.com/viewarticle/bio…
18
healio.com/news/pulmonology/…
Biologics lower rate of admissions requiring noninvasive ventilation in COPD

Biologics lower rate of admissions requiring noninvasive ventilation in COPD

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 inflammation significantly fell, according to a poster presented at the European...

healio.com
1
22
Presented at #ERS2025: After 1 year of biologic therapy, admissions requiring noninvasive #ventilation among patients with #COPD and type 2 inflammation significantly fell📉.   healio.com/news/pulmonology/…   @EuroRespSoc @Tru_Ho #NIV
Biologics lower rate of admissions requiring noninvasive ventilation in COPD

Biologics lower rate of admissions requiring noninvasive ventilation in COPD

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 inflammation significantly fell, according to a poster presented at the European...

healio.com
1
1
109
Biologics are increasingly utilized in COPD patients with T2 inflammation. Our study in BMC Pulmonary explores their impact on reducing systemic glucocorticoid burden bmcpulmmed.biomedcentral.com… @BMC_series @BioMedCentral @TemplePCCM @TempleLung
Reduction in systemic glucocorticoid utilization among COPD patients with type 2 inflammation...

Reduction in systemic glucocorticoid utilization among COPD patients with type 2 inflammation...

BMC Pulmonary Medicine - Systemic glucocorticoids are associated with significant side effects, however, are essential in the treatment of acute exacerbations of chronic obstructive pulmonary...

link.springer.com
2
81
🎉 Huge congratulations to the incredible graduates of the PCCM Class of 2025! You’ve worked so hard, grown so much, and we can’t wait to see all the amazing things you’ll do next!🌟 @JayyyyDr @DhananiZehra @DrMikeNicks @Tru_Ho @JensenGalvis @mbittner91 @MikeGouletDO
Image from TemplePCCM (@TemplePCCM)
1
3
25
994
Proud of our fellows representing Temple PCCM at #ISHLT2025! @DhananiZehra @Tru_Ho @DrMikeNicks Their work in lung transplant research continues to push the field forward. Grateful to our faculty mentors for their support and guidance. @fatimaanjum28 @TempleHealth @ISHLT
Fatima Anjum (@fatimaanjum28) profile pictureFatima Anjum@fatimaanjum2830 Apr 2025
Congratulations to all of our Lung transplant fellows on excellent work and presentations at #ISHLT2025 @ISHLT @TemplePCCM @TempleHealth
Image from Fatima Anjum (@fatimaanjum28)
Image from Fatima Anjum (@fatimaanjum28)
Image from Fatima Anjum (@fatimaanjum28)
Image from Fatima Anjum (@fatimaanjum28)
2
12
839
So excited to present this wonderful class of board-certified pulmonologists 🥳🎉 Seen here in the first week of fellowship to now being board-certified, we couldn’t be more proud! @JayyyyDr @DhananiZehra @DrMikeNicks @Tru_Ho @JensenGalvis @mbittner91 @MikeGouletDO
Image from TemplePCCM (@TemplePCCM)
3
3
19
952
Exploring the impact of comorbidities on patients with PE in Pulmonary Circulation - Analysis of a national database of 561k patients showed up to 5.4 fold increase in mortality in high comorbidity groups doi.org/10.1002/pul2.70010 @ParthRali @PVRI @PulmCirc @TemplePCCM
Image from Andrew Ho (@Tru_Ho)
3
1
18
2,042
Check out one of our second year fellows, Andrew Ho, in a video interview about his research presented at CHEST! ajmc.com/view/dr-andrew-ho-a… #MedTwitter #PCCMTwitter #templemade
Dr Andrew Ho: After PE Hospitalization, It’s Important to Look Into Logistical Options for Patients...

Dr Andrew Ho: After PE Hospitalization, It’s Important to Look Into Logistical Options for Patients...

Andrew Ho, MD, talks about the importance of searching for what can be modified, such as closer transition to skilled nursing facilities, when working with patients who had pulmonary embolism (PE)...

ajmc.com
4
8
1,245
🗨️#CHEST2023: "It was impactful to see the degree by which #mortality climbs with increasing #comorbidities in a large population [of adults hospitalized with #PE] reflective of the entire United States,” Andrew Ho, MD, at @TempleHealth, told Healio. bit.ly/45sDMLZ
Higher comorbidity burden raises odds for in-hospital mortality in patients with PE

Higher comorbidity burden raises odds for in-hospital mortality in patients with PE

HONOLULU — A higher comorbidity burden increases the odds for in-hospital mortality among adults with pulmonary embolism, according to a poster presented at the CHEST Annual Meeting.The chances for...

healio.com
1
157
Load more